Your browser is no longer supported. Please, upgrade your browser.
ResMed Inc.
IndexS&P 500 P/E69.97 EPS (ttm)3.12 Insider Own0.60% Shs Outstand145.51M Perf Week6.46%
Market Cap32.09B Forward P/E39.58 EPS next Y5.52 Insider Trans-6.90% Shs Float144.33M Perf Month13.65%
Income457.20M PEG3.43 EPS next Q1.27 Inst Own70.20% Short Float0.98% Perf Quarter18.07%
Sales3.09B P/S10.38 EPS this Y50.20% Inst Trans-1.37% Short Ratio2.34 Perf Half Y3.22%
Book/sh18.62 P/B11.74 EPS next Y5.08% ROA10.00% Target Price211.40 Perf Year38.17%
Cash/sh1.57 P/C139.17 EPS next 5Y20.40% ROE17.00% 52W Range157.08 - 224.43 Perf YTD2.83%
Dividend1.56 P/FCF61.56 EPS past 5Y11.50% ROI18.60% 52W High-2.61% Beta0.29
Dividend %0.71% Quick Ratio1.10 Sales past 5Y12.00% Gross Margin58.20% 52W Low39.15% ATR4.26
Employees7770 Current Ratio1.70 Sales Q/Q-0.10% Oper. Margin28.60% RSI (14)72.11 Volatility2.14% 1.73%
OptionableYes Debt/Eq0.27 EPS Q/Q-148.20% Profit Margin14.80% Rel Volume0.58 Prev Close220.53
ShortableYes LT Debt/Eq0.27 EarningsApr 29 AMC Payout49.50% Avg Volume607.60K Price218.58
Recom2.50 SMA207.42% SMA508.39% SMA20010.90% Volume351,126 Change-0.88%
Jun-09-21Upgrade CLSA Sell → Outperform
May-21-21Upgrade JP Morgan Neutral → Overweight $206 → $219
May-11-21Upgrade Citigroup Neutral → Buy
Apr-30-21Downgrade Citigroup Buy → Neutral
Mar-16-21Upgrade Needham Hold → Buy $229
Nov-02-20Upgrade UBS Neutral → Buy $210
Oct-30-20Upgrade JP Morgan Underweight → Neutral $165
Oct-27-20Upgrade BofA Securities Underperform → Neutral $186
Aug-07-20Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-17-20Upgrade Morgan Stanley Equal-Weight → Overweight
May-01-20Upgrade Oppenheimer Perform → Outperform $200
May-01-20Downgrade JP Morgan Neutral → Underweight
Feb-18-20Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-03-20Initiated CLSA Underperform
Jan-31-20Downgrade UBS Buy → Neutral $150 → $174
Jan-10-20Initiated Oppenheimer Perform
Nov-22-19Initiated KeyBanc Capital Markets Sector Weight
Jul-29-19Upgrade UBS Neutral → Buy $122 → $140
Jul-16-19Downgrade UBS Buy → Neutral
May-06-19Upgrade UBS Neutral → Buy $109 → $119
Jun-07-21 09:24AM  
Jun-04-21 10:10AM  
Jun-02-21 09:00AM  
May-25-21 04:05PM  
May-11-21 09:18AM  
May-07-21 02:33AM  
May-06-21 07:31AM  
May-03-21 10:00AM  
Apr-30-21 10:04AM  
Apr-29-21 11:31PM  
Apr-28-21 09:13AM  
Apr-27-21 09:00AM  
Apr-23-21 08:41AM  
Apr-22-21 05:54PM  
Apr-21-21 06:40AM  
Apr-14-21 12:06PM  
Apr-09-21 06:16AM  
Apr-08-21 04:05PM  
Mar-22-21 12:34PM  
Mar-16-21 09:00AM  
Mar-15-21 09:00AM  
Mar-12-21 11:43AM  
Mar-09-21 04:26PM  
Mar-08-21 05:27AM  
Feb-27-21 11:31AM  
Feb-10-21 05:43AM  
Feb-05-21 11:40AM  
Feb-03-21 11:06AM  
Feb-02-21 09:08AM  
Jan-29-21 09:59AM  
Jan-28-21 05:25PM  
Jan-27-21 10:15AM  
Jan-26-21 01:06PM  
Jan-22-21 06:35AM  
Jan-18-21 06:54AM  
Jan-14-21 11:40AM  
Jan-07-21 04:05PM  
Jan-05-21 09:00AM  
Jan-04-21 08:46AM  
Dec-30-20 09:57AM  
Dec-25-20 04:17AM  
Dec-23-20 03:18PM  
Dec-21-20 09:33AM  
Dec-18-20 10:15AM  
Dec-16-20 09:07AM  
Dec-15-20 08:46AM  
Dec-09-20 09:30AM  
Dec-08-20 10:12AM  
Dec-07-20 09:53AM  
Dec-04-20 11:10AM  
Dec-03-20 09:31AM  
Dec-02-20 10:45AM  
Dec-01-20 10:52AM  
Nov-30-20 01:44PM  
Nov-27-20 11:30AM  
Nov-26-20 09:06AM  
Nov-25-20 08:59AM  
Nov-24-20 11:13AM  
Nov-23-20 03:48PM  
Nov-19-20 11:08AM  
Nov-17-20 10:13AM  
Nov-12-20 08:46AM  
Nov-11-20 08:11AM  
Nov-09-20 02:11PM  
Nov-06-20 08:08AM  
Nov-05-20 11:30AM  
Nov-03-20 09:00AM  
Nov-02-20 01:07PM  
Oct-30-20 03:31AM  
Oct-29-20 06:05PM  
Oct-28-20 11:40AM  
Oct-26-20 12:10PM  
Oct-22-20 12:33PM  
Oct-19-20 06:50PM  
Oct-16-20 10:58AM  
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PENDARVIS DAVIDChief Administrative OfficerJun 03Sale207.001,487307,809126,387Jun 07 01:10 PM
Hollingshead JamesPresident, Sleep BusinessJun 01Sale206.032,400494,47578,338Jun 02 02:39 PM
Sodhi RajwantPresident, SaaS BusinessJun 01Sale207.131,500310,69527,165Jun 02 01:56 PM
Hollingshead JamesPresident, Sleep BusinessMay 21Sale202.012,400484,82480,738May 24 11:13 AM
Douglas Robert AndrewPresident and COO ResMed Inc.May 17Option Exercise58.248,000465,92016,767May 19 12:49 PM
Douglas Robert AndrewPresident and COO ResMed Inc.May 17Sale195.008,0001,560,0008,766May 19 12:49 PM
Sandercock BrettChief Financial OfficerMay 10Sale196.002,500490,00092,502May 11 07:07 PM
Sodhi RajwantPresident, SaaS BusinessMay 03Sale190.501,500285,75028,588May 04 01:55 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale190.501,487283,274127,807May 04 04:23 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Apr 15Sale207.45964199,982210,407Apr 16 03:12 PM
Hollingshead JamesPresident, Sleep BusinessApr 12Sale200.004,800960,00083,046Apr 13 05:23 PM
Sandercock BrettChief Financial OfficerApr 12Sale198.472,500496,17594,922Apr 13 05:22 PM
PENDARVIS DAVIDChief Administrative OfficerApr 05Sale196.151,487291,675129,294Apr 06 11:12 AM
Sodhi RajwantPresident, SaaS BusinessApr 01Sale194.141,500291,21030,088Apr 05 11:48 AM
Douglas Robert AndrewPresident and COO ResMed Inc.Mar 15Sale185.481,081200,504211,371Mar 16 06:31 PM
Sandercock BrettChief Financial OfficerMar 10Sale185.002,500462,50097,422Mar 11 05:43 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale191.801,487285,207130,781Mar 04 02:09 PM
Sodhi RajwantPresident, SaaS BusinessMar 01Sale194.341,500291,51031,588Mar 02 01:16 PM
TAYLOR RONALD RDirectorFeb 19Sale200.144,000800,56418,769Feb 22 11:48 AM
Douglas Robert AndrewPresident and COO ResMed Inc.Feb 16Sale200.46998200,059212,452Feb 17 04:47 PM
Sandercock BrettChief Financial OfficerFeb 10Sale201.372,500503,42599,922Feb 11 04:45 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Sale204.421,487303,973132,268Feb 05 01:11 PM
Hollingshead JamesPresident, Sleep BusinessFeb 01Sale200.182,400480,43787,846Feb 02 06:59 PM
Sodhi RajwantPresident, SaaS BusinessFeb 01Sale203.761,500305,64033,088Feb 02 01:28 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 15Sale212.86938199,663213,450Jan 19 05:24 PM
Sandercock BrettChief Financial OfficerJan 11Sale218.702,500546,750100,600Jan 12 04:11 PM
Hollingshead JamesPresident, Sleep BusinessJan 04Sale211.092,400506,61488,333Jan 05 04:52 PM
PENDARVIS DAVIDChief Administrative OfficerJan 04Sale213.241,487317,088132,207Jan 05 04:50 PM
Sodhi RajwantPresident, SaaS BusinessJan 04Sale213.241,500319,86032,675Jan 05 12:45 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 15Sale207.80970201,566214,388Dec 16 02:58 PM
Sandercock BrettChief Financial OfficerDec 10Sale211.062,500527,650103,100Dec 14 12:43 PM
PENDARVIS DAVIDChief Administrative OfficerDec 03Sale208.361,487309,831133,694Dec 07 12:41 PM
Hollingshead JamesPresident, Sleep BusinessDec 01Sale210.972,400506,33090,733Dec 01 07:37 PM
Sodhi RajwantPresident, SaaS BusinessDec 01Sale210.461,500315,69034,175Dec 02 05:57 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 24Sale211.00955201,505215,836Nov 25 11:50 AM
Sandercock BrettChief Financial OfficerNov 24Sale211.005,0001,055,000105,600Nov 25 06:01 PM
PENDARVIS DAVIDChief Administrative OfficerNov 20Option Exercise84.981,17699,936145,181Nov 24 01:31 PM
Leong JustinPresident, Asia Latin AmericaNov 05Option Exercise57.767,740447,06233,126Nov 13 09:03 PM
Leong JustinPresident, Asia Latin AmericaNov 05Sale211.367,7401,635,92625,386Nov 13 09:03 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise57.765,918341,824142,046Nov 05 02:01 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale201.145,9181,190,364136,128Nov 05 02:01 PM
Sodhi RajwantPresident, SaaS BusinessNov 02Sale195.161,500292,74031,089Nov 03 03:36 PM
Hollingshead JamesPresident, Sleep BusinessNov 02Sale195.002,400467,99687,602Nov 03 07:54 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Oct 15Sale176.721,125198,810182,313Oct 19 04:04 PM
Sandercock BrettChief Financial OfficerOct 15Sale176.722,500441,80084,275Oct 19 05:20 PM
PENDARVIS DAVIDChief Administrative OfficerOct 05Option Exercise57.765,919341,881142,047Oct 06 06:08 PM
PENDARVIS DAVIDChief Administrative OfficerOct 05Sale170.075,9191,006,621136,128Oct 06 06:08 PM
Sodhi RajwantPresident, SaaS BusinessOct 01Sale172.841,500259,26032,589Oct 02 04:46 PM
Hollingshead JamesPresident, Sleep BusinessOct 01Sale170.432,400409,02390,002Oct 02 04:44 PM
Sandercock BrettChief Financial OfficerSep 15Sale175.492,500438,72586,775Sep 16 06:35 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Sep 15Sale175.491,147201,287183,438Sep 16 05:01 PM
PENDARVIS DAVIDChief Administrative OfficerSep 03Option Exercise57.765,919341,881142,047Sep 04 05:00 PM
PENDARVIS DAVIDChief Administrative OfficerSep 03Sale177.525,9191,050,714136,128Sep 04 05:00 PM
Hollingshead JamesPresident, Sleep BusinessSep 01Sale202.022,400484,85492,402Sep 02 05:42 PM
Sodhi RajwantPresident, SaaS BusinessSep 01Sale181.001,500271,50034,089Sep 02 04:14 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Aug 17Sale177.551,132200,987184,585Aug 18 02:24 PM
Sandercock BrettChief Financial OfficerAug 17Sale177.552,500443,87589,275Aug 19 12:34 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise57.765,919341,881139,081Aug 04 08:01 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale201.995,9191,195,593133,162Aug 04 08:01 PM
Sodhi RajwantPresident, SaaS BusinessAug 03Sale200.061,500300,09028,261Aug 04 05:13 PM
Hollingshead JamesPresident, Sleep BusinessAug 03Sale202.022,400484,85487,474Aug 04 05:32 PM
Sandercock BrettChief Financial OfficerJul 15Sale196.982,500492,45084,796Jul 17 09:26 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jul 15Sale196.981,026202,101185,717Jul 17 11:27 AM
PENDARVIS DAVIDChief Administrative OfficerJul 06Option Exercise57.765,919341,881139,861Jul 07 03:14 PM
PENDARVIS DAVIDChief Administrative OfficerJul 06Sale194.645,9191,152,090133,942Jul 07 03:14 PM
Hollingshead JamesPresident, Sleep BusinessJul 01Sale189.632,400455,11289,874Jul 06 11:14 AM
Sodhi RajwantPresident, SaaS BusinessJul 01Sale189.491,500284,23529,761Jul 02 02:15 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jun 15Sale158.791,245197,694186,743Jun 16 07:45 PM
Sandercock BrettChief Financial OfficerJun 15Sale158.792,500396,97587,296Jun 16 07:43 PM